» Articles » PMID: 8100999

Interleukin 12 is Required for the T-lymphocyte-independent Induction of Interferon Gamma by an Intracellular Parasite and Induces Resistance in T-cell-deficient Hosts

Overview
Specialty Science
Date 1993 Jul 1
PMID 8100999
Citations 303
Authors
Affiliations
Soon will be listed here.
Abstract

Immunity against the intracellular protozoan Toxoplasma gondii is highly dependent on interferon gamma (IFN-gamma). We have previously shown that, in addition to T lymphocytes, natural killer (NK) cells can be stimulated by the parasite to produce this cytokine by a reaction requiring adherent accessory cells and tumor necrosis factor alpha. We now demonstrate that a recently characterized cytokine, interleukin 12 (IL-12), is also necessary for parasite-induced IFN-gamma synthesis by NK cells. Anti-IL-12 antibodies completely inhibited T. gondii or bacterial endotoxin-stimulated IFN-gamma production by NK-enriched spleen cells from severe combined immunodeficient mice. Moreover, potent NK cytokine responses were induced by the combination of IL-12 and tumor necrosis factor alpha. In addition, adherent spleen cells from scid/scid mice or thyoglycollate-elicited macrophages from BALB/c animals produced high levels of both IL-12 (p40) and tumor necrosis factor alpha mRNAs when exposed to either live tachyzoites, parasite extracts, or endotoxin, confirming that these cytokines are produced by accessory cells. Finally, in vivo studies showed that treatment with recombinant IL-12 results in prolonged survival of scid mice after infection with T. gondii by means of a response dependent on both IFN-gamma and NK cells. Together the data argue that IL-12 is required for the T-cell-independent triggering of NK cells by intracellular parasites and that the cytokine may be useful for inducing this protective pathway in immunodeficient hosts.

Citing Articles

IL-23 blockade in a patient with psoriasis and reactivation history: Case report and review.

Dagher J, Ringuet J SAGE Open Med Case Rep. 2025; 13:2050313X251320196.

PMID: 39967610 PMC: 11833812. DOI: 10.1177/2050313X251320196.


Toxoplasma gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma gondii.

Zhao L, Sun Q, Wang C, Liu J, Yan X, Shao M Int J Nanomedicine. 2024; 19:12421-12438.

PMID: 39600411 PMC: 11590659. DOI: 10.2147/IJN.S483626.


Caspase-1 in Cx3cr1-expressing cells drives an IL-18-dependent T cell response that promotes parasite control during acute Toxoplasma gondii infection.

Babcock I, Sibley L, Labuzan S, Cowan M, Sethi I, Alemu S PLoS Pathog. 2024; 20(10):e1012006.

PMID: 39446964 PMC: 11537422. DOI: 10.1371/journal.ppat.1012006.


T lymphocyte-dependent IL-10 down-regulates a cytokine storm driven by GRA24.

Doherty C, Patterson P, Emeanuwa J, Belmares Ortega J, Fox B, Bzik D mBio. 2024; 15(11):e0145524.

PMID: 39440975 PMC: 11559025. DOI: 10.1128/mbio.01455-24.


Toxoplasma gondii suppress human cord blood cell differentiation to the NK cell population.

Mahmoudzadeh S, Dizaji Asl K, Nozad Charoudeh H, Rahbarghazi R, Ahmadi M, Heidarzadeh M Immun Inflamm Dis. 2024; 12(6):e1329.

PMID: 39031850 PMC: 11191221. DOI: 10.1002/iid3.1329.


References
1.
Kobayashi M, Fitz L, Ryan M, Hewick R, Clark S, Chan S . Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989; 170(3):827-45. PMC: 2189443. DOI: 10.1084/jem.170.3.827. View

2.
Chehimi J, Starr S, Frank I, Rengaraju M, Jackson S, Llanes C . Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med. 1992; 175(3):789-96. PMC: 2119140. DOI: 10.1084/jem.175.3.789. View

3.
Bancroft G, Schreiber R, UNANUE E . Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev. 1991; 124:5-24. DOI: 10.1111/j.1600-065x.1991.tb00613.x. View

4.
Svetic A, Finkelman F, Jian Y, Dieffenbach C, Scott D, McCarthy K . Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol. 1991; 147(7):2391-7. View

5.
FRENKEL J . Pathophysiology of toxoplasmosis. Parasitol Today. 1988; 4(10):273-8. DOI: 10.1016/0169-4758(88)90018-x. View